WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global uncertainties.

NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the ...

Designated an Advanced Lighthouse in 2021, this latest recognition for Wuxi specifically acknowledges the factory's advanced ...